Pricing, Profits, and Technological Progress in the Pharmaceutical Industry

Keywords

Pharmaceutical industry, Incentive, Profitability index, Investment (military), Economics

References

• Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical IndustryRichard E. Caves, Michael D. Whinston, Mark A. Hurwitz — 1991
• The economic effects of compulsory patent licensingF. M. Scherer — 1977
• Pricing, Patent Loss and the Market For PharmaceuticalsRichard G. Frank, David S. Salkever — 1991
• The political economy of the pharmaceutical industry.Comanor Ws — 1986
• Technology, Regulation, and Market Structure in the Modern Pharmaceutical IndustryPeter Temin — 1979
• The Measurement of Corporate Rates of Return: A Generalized FormulationThomas Stauffer — 1971
• Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug ActHenry G. Grabowski, John M. Vernon — 1992
• Research and innovation in the modern corporationEdwin Mansfield, John Rapoport, Jerome Schnee — 1972
• Regulation and Firm Size: FDA Impacts on InnovationLacy Glenn Thomas — 1990
• Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical IndustryHenry G. Grabowski, John M. Vernon, Lacy Glenn Thomas — 1978
• The Weapons Acquisition Process: Economic IncentivesI. B. Holley, F. M. Scherer — 1965
• Medical care costs: how much welfare loss?Joseph P. Newhouse — 1992
• A New Look at the Returns and Risks to Pharmaceutical R&DHenry G. Grabowski, John M. Vernon — 1990
• Generics and New Goods in Pharmaceutical Price IndexesZvi Griliches, Iain Cockburn — 1993
• Cost of innovation in the pharmaceutical industry.Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski — 1991
• Welfare Effects of Global Patent ProtectionAlan V. Deardorff — 1992
• THE WORLD’S PHARMACEUTICAL INDUSTRIESRobert Ballance, Vienna Unido, János Pogány — 1992
• New Methods in Statistical EconomicsBenoît B. Mandelbrot — 1963
• Auditing the Producer Price Index: Micro Evidence From Prescription Pharmaceutical PreparationsErnst R. Berndt, Zvi Griliches, Joshua Rosett — 1992
• Economic and Political WeeklyU.S. Department of State — 2017

Cited by

• A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals.Esther Zana-Nau — 2003
• Accounting- versus economic-based rates of return: implications for profitability measures in the pharmaceutical industry.James A. Tompkins — 2004
• Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent ExpirationAlistair Kelman — 2005
• Post-approval fate of pharmaceutical companies.Ramón Pérez Parejo — 2015
• Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in ChinaMatthew Miltenberger — 2018
• Prescription drugs: issues of cost, coverage, and quality.Craig Copeland — 1999
• L'épuisement des droits de propriété industrielle dans l'espace OAPI (Organisation Africaine de la Propriété Intellectuelle)Ampah Johnson-Ansah — 2013
• R&D Investments, Profitability and Regulation of the Pharmaceutical IndustryIgor Goncharov, Jörg Mahlich, B. Burçin Yurtoğlu — 2017
• The success of the industrial development policy in the pharmaceutical industry in BangladeshMd Nurul Amin, Tetsushi Sonobe — 2013
• Generic-branded drug competition and the price for pharmaceuticals in procurement auctionsPaulo Roberto Arvate, Klênio Barbosa, Dante Gambardella — 2013
• Impact of patents on access to HIV / AIDS drugs in developing countries. [Preliminary version].Joan-Ramón Borrell, Jayashree Watal — 2002
• Market structure and regulation in pharmaceutical marketsCoronado Saleh, Francisco Javier — 2010
• OPEN SOURCE AND THE FUTURE OF THE PHARMACEUTICAL INSDUSTRYNeil B. Niman — 2004
• Global Competition and the United States Pharmaceutical IndustryLall Ramrattan, Michael Szenberg — 2006
• The Influence of Subject Areas on Middle School Tracking Policies. Faculty Research Working Paper Series R94-19.Tom Loveless — 1994
• Getting the most out of pharmaceutical expendituresHelen Saxenian — 1994
• AIDS Drugs For All: Social Movements and Market TransformationsEthan B. Kapstein, Joshua W. Busby — 2013
• Evaluation of incentives for R&D in the pharmaceutical industry with applications for neglected diseasesEshref Trushin — 2011
• Diagnosing policy dynamics: The birth & evolution of the pharmaceutical subsystemKatie R. Stores — 2009
• Sistema de precios de referencia en España: periodo 2000 - 2008M. Ferrer — 2010

Related papers

• Profitability in the car industry: New measures for estimating targets and target directionsHans van der Heijden, Wolfgang Garn — 2013
• Profitability Analysis of Acquiring CompaniesMonica Mogla, Fulbag Singh — 2010
• Profitability analysis of KINGLONG nearly 5 yearsZhang Mei, Jinghua Wen — 2017
• Analysis of profitability of production of enterprises in the field of transportation and storage of the Irkutsk regionE A Filatov — 2022
• Growth and profitability in small privately held biotech firms: preliminary findings.Malin Brännback, Alan L. Carsrud, Maija Renko — 2009
• Clariant significantly increases growth and further improves profitability in 20172018
• Analysis of the profitability of sales of small enterprises in the construction industry of the Irkutsk regionE A Filatov — 2022
• PRODUCTION PROFITABILITY ANALYSIS FOR SMALL CONSTRUCTION ENTERPRISES OF THE IRKUTSK REGIONE A Filatov — 2020
• The impact of Profitability of Indian Scheduled Commercial Banks – A Factor analysis approachDr.Kavitha Nachimuthu — 2019